1. Home
  2. SON vs TERN Comparison

SON vs TERN Comparison

Compare SON & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$50.78

Market Cap

4.9B

ML Signal

HOLD

Logo Terns Pharmaceuticals Inc.

TERN

Terns Pharmaceuticals Inc.

HOLD

Current Price

$52.97

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
TERN
Founded
1899
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.8B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
SON
TERN
Price
$50.78
$52.97
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$60.13
$45.22
AVG Volume (30 Days)
1.1M
6.2M
Earning Date
04-21-2026
05-14-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
8.04
EPS
0.68
N/A
Revenue
$7,518,753,000.00
N/A
Revenue This Year
$0.10
N/A
Revenue Next Year
$1.82
N/A
P/E Ratio
$74.31
N/A
Revenue Growth
41.72
N/A
52 Week Low
$38.65
$3.55
52 Week High
$58.44
$53.19

Technical Indicators

Market Signals
Indicator
SON
TERN
Relative Strength Index (RSI) 55.69 74.51
Support Level $46.04 $52.42
Resistance Level $52.71 $53.19
Average True Range (ATR) 1.38 0.07
MACD 0.37 -0.31
Stochastic Oscillator 89.03 97.30

Price Performance

Historical Comparison
SON
TERN

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Share on Social Networks: